Prevalence, awareness, treatment and control of type 2 diabetes in southeast China: A population-based study

被引:2
|
作者
Hu, Xiangju [1 ,2 ]
Fang, Xin [2 ]
Wu, Minxia [3 ]
机构
[1] Fujian Med Univ, Sch Publ Hlth, Fuzhou, Peoples R China
[2] Fujian Prov Ctr Dis Control & Prevent, Dept Chron & Noncommunicable Dis Control & Prevent, Fuzhou, Peoples R China
[3] Fujian Med Univ, Publ Technol Serv Ctr, Fuzhou, Peoples R China
关键词
Diabetes; Influence factors; Treatment; Type; 2; RISK;
D O I
10.1111/jdi.14213
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims/IntroductionTo estimate the prevalence, awareness, treatment, control rate, and influence factors of type 2 diabetes in Fujian province and provide the scientific basic for prevention.Materials and MethodsA population-based study with the analysis of binary logistic regression was carried out to estimate the odds ratios of the influencing factor on type 2 diabetes. Data of the Patient-Centered Evaluative Assessment of Cardiac Events (PEACE) in southeast China were used. The study sample originated from 12 counties in Fujian province and included 135,352 permanent residents aged 35-75 years in 2021.ResultsThe prevalence of type 2 diabetes was 18.32% (24,801/135,352). Among them, 13,921 (56.13%) were aware of their condition, 11,894 (47.96%) were receiving treatment, and 4,537 (18.29%) had achieved control of blood glucose. Multivariate logistic regression analysis showed that older age, men, low-family income, low-education level, urban locality, no medical insurance, and histories of myocardial infarction, stroke, dyslipidemia, hypertension, alcohol consumption, and obesity were associated with a higher prevalence of type 2 diabetes.ConclusionsThe prevalence of type 2 diabetes among residents aged 35-75 years in southeast China is high, whereas the status of its low awareness, treatment and control is severe, warranting a broad-based global strategy, including greater efforts in earlier screening, and more effective and affordable treatment is essential. The prevalence of type 2 diabetes among residents aged 35-75 years in southeast China is high, whereas the status of its low awareness, treatment and control is severe, warranting a broad-based global strategy, including greater efforts in earlier screening, and more effective and affordable treatment is essential. image
引用
收藏
页码:1034 / 1041
页数:8
相关论文
共 50 条
  • [31] Trends in Hypertension Prevalence, Awareness, Treatment and Control in an Adult Type 2 Diabetes Spanish Population between 2003 and 2009
    de Burgos-Lunar, Carmen
    Jimenez-Garcia, Rodrigo
    Salinero-Fort, Miguel A.
    Gomez-Campelo, Paloma
    Gil, Angel
    Abanades-Herranz, Juan C.
    Cardenas-Valladolid, Juan
    del Cura-Gonzalez, Isabel
    PLOS ONE, 2014, 9 (01):
  • [32] Regional differences in diabetes prevalence and awareness between coastal and interior provinces in China: a population-based cross-sectional study
    Xu, Shaoyong
    Ming, Jie
    Xing, Ying
    Gao, Bin
    Yang, Chunbao
    Ji, Qiuhe
    Chen, Gang
    BMC PUBLIC HEALTH, 2013, 13
  • [33] Regional differences in diabetes prevalence and awareness between coastal and interior provinces in China: a population-based cross-sectional study
    Shaoyong Xu
    Jie Ming
    Ying Xing
    Bin Gao
    Chunbao Yang
    Qiuhe Ji
    Gang Chen
    BMC Public Health, 13
  • [34] Seasonality in the incidence of type 2 diabetes -: A population-based study
    Doró, P
    Benko, R
    Matuz, M
    Soós, G
    DIABETES CARE, 2006, 29 (01) : 173 - 173
  • [35] The cost of type 2 diabetes: a population-based study in Catalonia
    Vinagre, I.
    Mata-Cases, M.
    Franch-Nadal, J.
    Casajuana, M.
    Morros, R.
    Hermosilla, E.
    Fina, F.
    Castell, C.
    Bolivar, B.
    Mauricio, D.
    DIABETOLOGIA, 2013, 56 : S468 - S468
  • [36] Prevalence of Autoimmune Diabetes in China: A Nationwide Population-Based Survey
    Zhou, Zhiguang
    Yang, Wenying
    Ji, Linong
    Weng, Jianping
    Jia, Weiping
    Lu, Juming
    Xiao, Jianzhong
    Shan, Zhongyan
    Liu, Jie
    Tian, Haoming
    Ji, Qiuhe
    Zhu, Dalong
    Ge, Jiapu
    Lin, Lixiang
    Chen, Li
    Guo, Xiaohui
    Zhao, Zhigang
    Li, Qiang
    Huang, Gan
    Feng, Qiong
    Xiang, Yufei
    DIABETES, 2013, 62 : A63 - A63
  • [37] Prevalence, awareness and control of type 2 diabetes mellitus and risk factors in Chinese elderly population
    Yaqiong Yan
    Tingting Wu
    Miao Zhang
    Changfeng Li
    Qing Liu
    Fang Li
    BMC Public Health, 22
  • [38] Prevalence, awareness and control of type 2 diabetes mellitus and risk factors in Chinese elderly population
    Yan, Yaqiong
    Wu, Tingting
    Zhang, Miao
    Li, Changfeng
    Liu, Qing
    Li, Fang
    BMC PUBLIC HEALTH, 2022, 22 (01)
  • [39] Prevalence and Determinants of Hypertension Awareness, Treatment, and Control in Botswana: A Nationally Representative Population-Based Survey
    Tapela, Neo M.
    Clifton, Lei
    Tshisimogo, Gontse
    Gaborone, Moagi
    Madidimalo, Tebogo
    Letsatsi, Virginia
    Masupe, Tiny
    Mosepele, Mosepele
    Makhema, Joseph
    Lockman, Shahin
    Hunter, David J.
    INTERNATIONAL JOURNAL OF HYPERTENSION, 2020, 2020
  • [40] Prevalence, awareness, treatment and control of dyslipidaemia and their determinants: results from a population-based survey of 60 283 residents in eastern China
    Chen, Yijia
    Du, Jinling
    Zhou, Nan
    Song, Yingqian
    Wang, Weiwei
    Hong, Xin
    BMJ OPEN, 2023, 13 (12):